Dr. Mark Silverberg is the director of the Toronto Immune and Digestive Health Center and is a professor at the Department of Medicine at the University of Toronto. He leads a clinical research program that focuses on the causes of IBD, the development of tools to improve the management of IBD patients, and the development of novel IBD therapies. He has contributed to the discovery of genes related to IBD as well as being a major contributor to the field of classification of IBD.
Dr. Séverine Vermeire is affiliated with the Gastroenterology Department of the University Hospitals in Leuven, Belgium, and is also a professor of medicine at the Catholic University of Belgium. Her work has focused on the genetics and pharmacogenetics of IBD, on the role of the microbiome in IBD, and on aspects related to the immunogenicity of biological therapies.
Dr. Bram Verstockt is a gastroenterologist holding positions as a clinician and researcher in both the Department of Gastroenterology and Hepatology and the Department of Chronic Diseases and Metabolism at the University Hospitals in Leuven, Belgium. He is interested in translational research focusing primarily on the development of predictive and prognostic markers as part of a precision approach, and also utilizes mult-omics as a tool.
Thank you so much! It has been intense especially for their finance person. She is the unsung hero and probably got 0 sleep from the past 6 months.Were you one of the people in the picture of the propellors? I actually donated btw.